Medicover Genetics at Medlab Middle East 2025!

Medicover Genetics Editorial Team|

Scientifically checkedView our editorial guidelines
Scientifically checked

Medicover Genetics is excited to announce our participation in Medlab Middle East 2025, taking place from February 3-6, 2025, at the Dubai World Trade Centre. As the largest gathering in laboratory medicine in the region, this prestigious event is where innovation meets expertise.

Visitors to our booth will have the opportunity to meet our team of experts and learn about our versatile Technology Transfer Platform. Our platform is designed to empower laboratories to deploy high-fidelity genetic services in-house. We will also showcase our NGS-based CE IVD multidisciplinary solutions, tailored to meet the unique needs of laboratories worldwide. Our experts are available to discuss how we can support your laboratory’s needs and enhance your laboratory’s capabilities.

Our team will hold insightful daily presentations covering key topics in genetic diagnostics:

  • Driving Innovation in Genetic Diagnostics with Medicover Genetics Tech Transfer Platform and Multidisciplinary Assays
  • Optimizing Diagnostic Solutions to Enhance the Reproductive Health Journey
  • Unlocking the Genomic Landscape of Cancer: A Comprehensive Portfolio to Empower Precision Medicine

We look forward to connecting with you at Medlab Middle East 2025 and discussing how Medicover Genetics can empower your genetic diagnostics capabilities.

Last updated: June 8, 2026

Latest articles

All about genetics
Health and well-being
Hereditary diseases

  • VERACITY

    New-generation non-invasive prenatal screening from week 9 of pregnancy, analysing fetal cell-free DNA in maternal blood to detect selected chromosomal abnormalities with high sensitivity and specificity for early and reliable prenatal risk assessment.

  • Pharmacogenomics

    Enabling personalised treatments for safer, more effective care through genetic insights that guide optimal prescribing from the start and refine therapy when patients experience side effects or poor response.

  • ebiom+

    A comprehensive assessment of the endometrial microbiome and chronic endometritis pathogens to enhance clinical outcomes, prevent treatment delays, and support a more informed, personalised fertility care.

  • WES

    Advanced sequencing that simultaneously analyses a broad range of genes to detect the genetic basis of complex diseases, improve diagnostic accuracy, and inform recurrence risk assessment for better clinical decision-making.

Why Medicover Genetics

Leader in genetic testing with >25 years of experience in counselling and diagnostics

Comprehensive CE-IVD kit portfolio and seamless Technology Transfer solution for laboratories of any size

End-to-end clinical workflow from sample processing to sequencing analysis and reporting

CAP- and CLIA- and ISO15189 accredited, GMP- and ISO9001 and 13485 certified

Are you a patient?

Are you a physician?